Taiwan · Delayed Price · Currency is TWD Synbio Tech Statistics
Total Valuation
Synbio Tech has a market cap or net worth of TWD 1.72 billion. The enterprise value is 3.00 billion.
| Market Cap | 1.72B |
| Enterprise Value | 3.00B |
Important Dates
The next estimated earnings date is Monday, August 10, 2026.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | Mar 27, 2026 |
Share Statistics
Synbio Tech has 34.48 million shares outstanding. The number of shares has increased by 9.40% in one year.
| Current Share Class | 34.48M |
| Shares Outstanding | 34.48M |
| Shares Change (YoY) | +9.40% |
| Shares Change (QoQ) | -0.52% |
| Owned by Insiders (%) | 22.30% |
| Owned by Institutions (%) | n/a |
| Float | 17.79M |
Valuation Ratios
The trailing PE ratio is 11.50.
| PE Ratio | 11.50 |
| Forward PE | n/a |
| PS Ratio | 1.69 |
| PB Ratio | 1.38 |
| P/TBV Ratio | 1.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 11.98 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.38, with an EV/FCF ratio of -5.75.
| EV / Earnings | 20.01 |
| EV / Sales | 2.94 |
| EV / EBITDA | 11.38 |
| EV / EBIT | 17.60 |
| EV / FCF | -5.75 |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 1.33.
| Current Ratio | 1.04 |
| Quick Ratio | 0.52 |
| Debt / Equity | 1.33 |
| Debt / EBITDA | 6.33 |
| Debt / FCF | -3.20 |
| Interest Coverage | 8.22 |
Financial Efficiency
Return on equity (ROE) is 13.21% and return on invested capital (ROIC) is 6.10%.
| Return on Equity (ROE) | 13.21% |
| Return on Assets (ROA) | 3.67% |
| Return on Invested Capital (ROIC) | 6.10% |
| Return on Capital Employed (ROCE) | 7.19% |
| Weighted Average Cost of Capital (WACC) | 4.52% |
| Revenue Per Employee | 11.08M |
| Profits Per Employee | 1.63M |
| Employee Count | 92 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 2.15 |
Taxes
In the past 12 months, Synbio Tech has paid 18.49 million in taxes.
| Income Tax | 18.49M |
| Effective Tax Rate | 10.98% |
Stock Price Statistics
The stock price has decreased by -29.58% in the last 52 weeks. The beta is 0.65, so Synbio Tech's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | -29.58% |
| 50-Day Moving Average | 58.38 |
| 200-Day Moving Average | 91.00 |
| Relative Strength Index (RSI) | 35.77 |
| Average Volume (20 Days) | 88,232 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Synbio Tech had revenue of TWD 1.02 billion and earned 149.95 million in profits. Earnings per share was 4.35.
| Revenue | 1.02B |
| Gross Profit | 531.25M |
| Operating Income | 170.48M |
| Pretax Income | 168.43M |
| Net Income | 149.95M |
| EBITDA | 260.20M |
| EBIT | 170.48M |
| Earnings Per Share (EPS) | 4.35 |
Balance Sheet
The company has 392.44 million in cash and 1.67 billion in debt, with a net cash position of -1.28 billion or -37.03 per share.
| Cash & Cash Equivalents | 392.44M |
| Total Debt | 1.67B |
| Net Cash | -1.28B |
| Net Cash Per Share | -37.03 |
| Equity (Book Value) | 1.25B |
| Book Value Per Share | 36.28 |
| Working Capital | 39.62M |
Cash Flow
In the last 12 months, operating cash flow was 143.83 million and capital expenditures -666.04 million, giving a free cash flow of -522.21 million.
| Operating Cash Flow | 143.83M |
| Capital Expenditures | -666.04M |
| Depreciation & Amortization | 89.72M |
| Net Borrowing | 636.48M |
| Free Cash Flow | -522.21M |
| FCF Per Share | -15.15 |
Margins
Gross margin is 52.11%, with operating and profit margins of 16.72% and 14.71%.
| Gross Margin | 52.11% |
| Operating Margin | 16.72% |
| Pretax Margin | 16.52% |
| Profit Margin | 14.71% |
| EBITDA Margin | 25.52% |
| EBIT Margin | 16.72% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 6.00%.
| Dividend Per Share | 3.00 |
| Dividend Yield | 6.00% |
| Dividend Growth (YoY) | -39.64% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 73.19% |
| Buyback Yield | -9.40% |
| Shareholder Yield | -3.40% |
| Earnings Yield | 8.70% |
| FCF Yield | -30.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 6, 2024. It was a forward split with a ratio of 1.02.
| Last Split Date | Aug 6, 2024 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Synbio Tech has an Altman Z-Score of 1.68 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.68 |
| Piotroski F-Score | 3 |